Anticardiolipin antibodies and antibodies to beta(2)-glycoprotein I in patients with Wegener's granulomatosis. 2000

P Lamprecht, and K deGroot, and A Schnabel, and E Csernok, and B Liedvogel, and W L Gross

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014890 Granulomatosis with Polyangiitis A multisystemic disease of a complex genetic background. It is characterized by inflammation of the blood vessels (VASCULITIS) leading to damage in any number of organs. The common features include granulomatous inflammation of the RESPIRATORY TRACT and KIDNEYS. Most patients have measurable autoantibodies (ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES) against MYELOBLASTIN. Granulomatosis, Wegener's,Wegener Granulomatosis,Wegener's Granulomatosis,Granulomatosis with Polyangiitides,Granulomatosis, Wegener,Polyangiitides, Granulomatosis with,Polyangiitis, Granulomatosis with,with Polyangiitides, Granulomatosis,with Polyangiitis, Granulomatosis
D017153 Antibodies, Anticardiolipin Antiphospholipid antibodies found in association with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. The antibodies are detected by solid-phase IMMUNOASSAY employing the purified phospholipid antigen CARDIOLIPIN. Anticardiolipin Antibodies,Anticardiolipin Autoantibodies,Anticardiolipin Autoantibody,Cardiolipin Autoantibodies,Cardiolipin Autoantibody,Anticardiolipin Antibody,Antibody, Anticardiolipin,Autoantibody, Anticardiolipin,Autoantibody, Cardiolipin
D053482 beta 2-Glycoprotein I A 44-kDa highly glycosylated plasma protein that binds phospholipids including CARDIOLIPIN; APOLIPOPROTEIN E RECEPTOR; membrane phospholipids, and other anionic phospholipid-containing moieties. It plays a role in coagulation and apoptotic processes. Formerly known as apolipoprotein H, it is an autoantigen in patients with ANTIPHOSPHOLIPID ANTIBODIES. Apolipoprotein H,Anticardiolipin Cofactor,Apo H,EC-VMFa,Endothelial Cell-Viability Maintaining Factor,beta(2)GPI,beta2-Glycoprotein I,Cofactor, Anticardiolipin,EC VMFa,Endothelial Cell Viability Maintaining Factor,beta 2 Glycoprotein I,beta2 Glycoprotein I

Related Publications

P Lamprecht, and K deGroot, and A Schnabel, and E Csernok, and B Liedvogel, and W L Gross
August 1994, Clinical immunology and immunopathology,
P Lamprecht, and K deGroot, and A Schnabel, and E Csernok, and B Liedvogel, and W L Gross
April 1996, Lupus,
P Lamprecht, and K deGroot, and A Schnabel, and E Csernok, and B Liedvogel, and W L Gross
February 2005, Autoimmunity,
P Lamprecht, and K deGroot, and A Schnabel, and E Csernok, and B Liedvogel, and W L Gross
January 2023, Journal of clinical laboratory analysis,
P Lamprecht, and K deGroot, and A Schnabel, and E Csernok, and B Liedvogel, and W L Gross
December 1998, Leprosy review,
P Lamprecht, and K deGroot, and A Schnabel, and E Csernok, and B Liedvogel, and W L Gross
October 1990, Lancet (London, England),
P Lamprecht, and K deGroot, and A Schnabel, and E Csernok, and B Liedvogel, and W L Gross
February 2023, The American journal of the medical sciences,
P Lamprecht, and K deGroot, and A Schnabel, and E Csernok, and B Liedvogel, and W L Gross
October 1994, Arthritis and rheumatism,
P Lamprecht, and K deGroot, and A Schnabel, and E Csernok, and B Liedvogel, and W L Gross
November 2003, Annals of the rheumatic diseases,
P Lamprecht, and K deGroot, and A Schnabel, and E Csernok, and B Liedvogel, and W L Gross
July 1998, The Journal of rheumatology,
Copied contents to your clipboard!